Last updated: March 24, 2023
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting
Phase
N/A
Condition
Depression
Dementia
Treatment
Tailored Active intervention
Inactive intervention
Clinical Study ID
NCT01816152
7R01AG034157-11
Ages > 60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- mild to moderate Alzheimer's disease and related dementia (ADRD) based on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria,
- Clinical Dementia Rating (CDR) of 1 to 2,
- Mini-Mental State Examination (MMSE) between 8 and 24
Exclusion
Exclusion Criteria:
- major organ failure,
- major illness,
- history of head injury,
- hypertension or diabetes,
- use psychotropic (sleep aid) medicine, obstructing cataracts, macular degeneration, and blindness
Study Design
Total Participants: 45
Treatment Group(s): 2
Primary Treatment: Tailored Active intervention
Phase:
Study Start date:
January 01, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Icahn School of Medicine at Mount Sinai
New York, New York 10029
United StatesActive - Recruiting
Icahn School of Medicine at Mount Sinai
Troy, New York 12180
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.